Analyst Ratings published Tuesday June 9th 2026

6/9/26	Upgrades	Neutral Buy	X
AJG Arthur J. Gallagher UBS
$250
6/9/26	Upgrades	Neutral Buy	X
BRC Brady Sidoti
$103
6/9/26	Initiated	Outperform	X
DTIL Precision BioSciences Oppenheimer
$20
6/9/26	Initiated	Buy	X
ELVN Enliven Therapeutics Stifel
$60
6/9/26	Downgrades	Outperform Sec Perform	X
EQR Equity Residential RBC Capital Mkts
$70
6/9/26	Upgrades	Hold Buy	X
FCEL FuelCell Energy Canaccord Genuity
$30
6/9/26	Initiated	Buy	X
GOLD Gold.com Canaccord Genuity
$70
6/9/26	Downgrades	Outperform Perform	X
INGR Ingredion Oppenheimer
6/9/26	Resumed	Buy	X
JAZZ Jazz Pharma Truist
$256
6/9/26	Downgrades	Mkt Perform Underperform	X
LEN Lennar Keefe Bruyette
$86
6/9/26	Initiated	Buy	X
LOPE Grand Canyon Education Truist
$200
6/9/26	Initiated	Outperform	X
LYTS LSI Industries Oppenheimer
$30
6/9/26	Initiated	Buy	X
MGNI Magnite BTIG Research
$20
6/9/26	Upgrades	Underweight Neutral	X
PAR PAR Technology JP Morgan
$16
6/9/26	Initiated	Mkt Outperform	X
PKE Park Aerospace Citizens
$42
6/9/26	Initiated	Market Outperform	X
PRM Perimeter Solutions CJS Securities
$48
6/9/26	Downgrades	Buy Hold	X
PRU Prudential Argus
6/9/26	Upgrades	Neutral Buy	X
PTCT PTC Therapeutics Citigroup
$108
6/9/26	Upgrades	Mkt Perform Outperform	X
TOL Toll Brothers Keefe Bruyette
$161
6/9/26	Initiated	Outperform	X
VEON VEON Northland Capital
$70
6/9/26	Initiated	Buy	X
WPP WPP plc Berenberg
6/9/26	Upgrades	Eq Weight Overweight	X
WST West Pharm Barclays
$400
6/9/26	Resumed	Buy	X
ZYME Zymeworks Truist
$28